Related Experiment Videos
Red cell 2,3-diphosphoglycerate and adenosine triphosphate in patients with shock
British Journal of Haematology
|August 1, 1971
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Granulocyte-macrophage colony stimulating factor (GM-CSF) priming in the treatment of elderly patients with acute myelogenous leukemia.
American journal of hematology·1995
Phase I/II study of cyclophosphamide, carboplatin, and etoposide and autologous hematopoietic stem-cell transplantation with posttransplant interferon alfa-2b for patients with lymphoma and Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1994
Treatment of acute myeloid leukemia in the elderly with low-dose cytarabine, hydroxyurea, and calcitriol.
American journal of hematology·1992
Trisomy 13q in a case of acute leukemia with lineage inconsistency.
Cancer genetics and cytogenetics·1991
Sickle cell disease and commercial aviation. A retrospective analysis of in-flight and pre-flight medical events.
British journal of haematology·2026
LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.
British journal of haematology·2026
Autoimmune neutropenia in children: Test cells versus beads and a role for pro-LL-37 and absolute neutrophil count.
British journal of haematology·2026
Real-world outcomes of ide-cel and cilta-cel in relapsed/refractory multiple myeloma: A nationwide, retrospective analysis in Austria.
British journal of haematology·2026
Long-term results of brentuximab vedotin and bendamustine for first-line treatment of Hodgkin lymphoma in the elderly (HALO trial).
British journal of haematology·2026
[Pharmacologic treatment of dystonia].
Medicina·2026
Oral vs. Subcutaneous Semaglutide for Obesity Treatment: A Systematic Review of Efficacy, Safety, and Patient-Oriented Outcomes.
Pharmaceuticals (Basel, Switzerland)·2026
Development of a PK/PD-Efficacy Modeling Framework for Covalent Inhibitors.
Pharmaceuticals (Basel, Switzerland)·2026
Novel Roles of Urokinase- and Tissue-Type Plasminogen Activators in Substance Use Disorders: A Narrative Review of Molecular Mechanisms and Translational Perspectives.
International journal of molecular sciences·2026